April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Combined Effect of Diquafosol Tetrasodium and Sodium Hyaluronate Ophthalmic Solutions on the Tear Fluid Volume in Normal Rabbits by Measurements of the Tear Meniscus Area
Author Affiliations & Notes
  • Yuko Takaoka-Shichijo
    Research & Development Center, Santen Pharmaceutical Co. Ltd., Ikoma-Shi, Japan
  • Naoko Yamashita
    Research & Development Center, Santen Pharmaceutical Co. Ltd., Ikoma-Shi, Japan
  • Masatsugu Nakamura
    Research & Development Center, Santen Pharmaceutical Co. Ltd., Ikoma-Shi, Japan
  • Footnotes
    Commercial Relationships  Yuko Takaoka-Shichijo, Santen Pharmaceutical Co. Ltd. (E); Naoko Yamashita, None; Masatsugu Nakamura, Santen Pharmaceutical Co. Ltd. (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3783. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuko Takaoka-Shichijo, Naoko Yamashita, Masatsugu Nakamura; Combined Effect of Diquafosol Tetrasodium and Sodium Hyaluronate Ophthalmic Solutions on the Tear Fluid Volume in Normal Rabbits by Measurements of the Tear Meniscus Area. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3783.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : It is reported that the P2Y2 receptor agonist, diquafosol tetrasodium, stimulated tear fluid secretion on Schirmer test. On the other hand, sodium hyaluronate is known to have a good water retention property, although its viscosity makes it difficult to measure tear fluid volume by Schirmer test. We have evaluated the combined effect of diquafosol tetrasodium and sodium hyaluronate ophthalmic solutions on the tear fluid volume of normal rabbits by measurements of the tear meniscus area.

Methods: : The tear fluid volume on the rabbits was measured to obtain the Schirmer test value with topical anesthesia. To measure the tear meniscus area, digital photographs with a blue filter were taken to cover the whole area after instilling 3 µ L of 0.1% fluorescien dye without topical anesthesia. The tear meniscus area was then calculated by WinRoof, software for digital imaging analysis. The efficacy was shown as Δ tear meniscus area (Δ value), that is, the difference observed before and after instillation of each ophthalmic solution.

Results: : The volume of external instillation to the ocular surface was accurately reflected in the Δ value. The efficacy of 0.1% sodium hyaluronate could not be confirmed by the Schirmer test, however, the Δ value of sodium hyaluronate was higher than that of artificial tears for 5 min after instillation. The efficacy of 3% diquafosol tetrasodium on the Δ values at 5-30 min after instillation was higher than that of sodium hyaluronate. The combined effect of diquafosol tetrasodium and sodium hyaluronate on the Δ value was higher than that of the single instillation of diquafosol tetrasodium or sodium hyaluronate at 5 and 30 min.

Conclusions: : Measurement of the tear meniscus area was found to be a minimally invasive and useful method to evaluate the tear fluid volume. The combination of diquafosol tetrasodium and sodium hyaluronate seems to keep the tear fluid on the ocular surface more and longer than that of the single instillation of either drug. Thus, a combination of diquafosol tetrasodium and sodium hyaluronate may offer a more effective for dry eye than a single treatment.

Keywords: cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×